Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Overview: Vivendi SE is a global entertainment, media, and communication company with operations across Europe, the Americas, Asia/Oceania, and Africa, and has a market cap of approximately €8.90 ...